Morningstar (NASDAQ: MORN) Executive Chairman Mansueto sells $1.79 million of shares

What happened

Morningstar, Inc. (NASDAQ: MORN) Executive Chairman Joseph D. Mansueto sold 7,250 common shares on Nov. 5 for about $1.79 million. Mansueto is also a director and a 10% owner of the company.

The Form 4 says the sales were made under a Rule 10b5-1 trading plan that Mansueto adopted on June 8.

The shares went in five lots at weighted average prices from $244.96 to $248.78. The largest lot was 2,932 shares at $246.91. After the sales, Mansueto held 8,587,179 shares directly.

The Form 4 separately lists 5,600,034 shares held in grantor retained annuity trusts for the benefit of Mansueto and Mansueto's children, with Mansueto as trustee. It also lists 150,000 shares in trusts for Mansueto's children, with Mansueto's spouse as trustee.

Key numbers

Metric	Latest	Change	Source
Shares sold	7,250 shares		SEC Form 4
Total proceeds	about $1.79 million		SEC Form 4
Reported sale price range	$244.96 to $248.78 per share		SEC Form 4
Shares held directly after the sale	8,587,179 shares		SEC Form 4
Sale as share of direct holding before the trade	about 0.1%		Calculated from SEC Form 4

Read more: Morningstar (MORN) company research

Why it matters

The sale is very small against what Mansueto owns. OptimistFi calculates that it was about 0.1% of Mansueto's direct holding before the trade.

The trust holdings sit outside that calculation. The Form 4 lists the annuity trusts and the children's trusts on separate lines from the direct holding, so the trade changed only the shares Mansueto holds in Mansueto's own name. Mansueto remains an Executive Chairman, a director and a 10% owner after the sale.

OptimistFi has argued that Morningstar turns sticky subscription data and research into high-margin recurring revenue that funds M&A and shareholder returns. A sale this size leaves that view unchanged.

The plan structure also limits what the trade can tell investors. Because the sales were made under a Rule 10b5-1 trading plan adopted on June 8, before the Nov. 5 sales, they are a weak read on Morningstar's business prospects in either direction.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

The next test is Morningstar's next quarterly report. Steady recurring revenue and cash flow would back OptimistFi's view, while pressure from regulation or competition, the threats the view names, would weaken it.

Another Form 4 from Mansueto would report any further sales under the June 8 plan.

More from OptimistFi

• MORN stock: research and coverage of Morningstar
• Stock research on every company OptimistFi covers

From OptimistFi Perps